Changjiang Pharmaceutical Group Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Changjiang Pharmaceutical Holdings Co., Ltd., formerly known as Kangyue Technology Co., Ltd., was listed on the Growth Enterprise Market of Shenzhen Stock Exchange on August 1, 2014. Its main business was the research and development, production, and sales of internal combustion engine parts. In December 2020, it obtained control of Hubei Changjiang Star Pharmaceutical Co., Ltd. After divesting its internal combustion engine business in 2022, the company was renamed Changjiang Pharmaceutical Holdings Co., Ltd., with the securities abbreviation being "Changyao Holdings", The securities code is "300391", becoming a pharmaceutical enterprise that focuses fully on the big health industry. |
| Headquarter | Weifang |
| Establish Date | 12/24/2001 |
| Listed Code | 300391.SZ |
| Listed Date | 8/1/2014 |
| Chairman | Li Jinfeng. |
| CEO | Luoming. |
| Website | www.chinakangyue.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
